Auxilium Parmaceuticals, Inc. | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Auxilium Parmaceuticals, Inc.

Sort by

Viewing results 1‒4 of 4

US & Canadian companies
Endo looks to crash $14.5bn Valeant-Salix deal
...In his letter, Mr De Silva pointed out that the company’s most recent acquisition, the $2.6bn takeover of Auxilium, was approved with a “resounding margin”....
March 11, 2015
Asia-Pacific equities
TDK buys Germany’s Epcos for $1.9bn
...Takeda Parmaceutical has said it will pay $8.8bn to take over Millennium, a US biotechnology company, while Daiichi Sankyo offered $4.6bn for Ranbaxy Laboratories, India’s biggest generic drugs maker....
July 31, 2008
FT Live
FTWeekend Festival: U.S. edition
Where the Financial Times weekend paper comes to life
Saturday, 4 MayThe REACH, at the Kennedy Center for the Performing Arts, F Street Northwest, Washington, DC, USA
US downturn
Wall Street exude caution ahead of payrolls
...In contrast, Auxilium Pharmaceuticals slid 9.3 per cent to $14.47 after the speciality drug-maker stopped a late-stage clinical trial....
December 7, 2006
US downturn
Wall Street rises amid heated trading
...In contrast, Auxilium Pharmaceuticals slid 13.8 per cent to $14.35 after the speciality drugsmaker stopped a late-stage clinical trial....
December 8, 2006

Previous pagePage 1 of 1Next page